Correction: Characteristic analysis of TCR &#x03B2;-chain CDR3 repertoire for preand post-liver transplantation

Guiqi Yang; Minglin Ou; Huaizhou Chen; Changchun Guo; Jiejing Chen; Hua Lin; Donge Tang; Wen Xue; Wenlong Li; Weiguo Sui; Yong Dai

doi:10.18632/oncotarget.27560

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Characteristic analysis of TCR β-chain CDR3 repertoire for preand post-liver transplantation

PDF | How to cite

Oncotarget. 2020; 11:1679-1679. https://doi.org/10.18632/oncotarget.27560

Metrics: PDF 1073 views | ?

Guiqi Yang^1,*, Minglin Ou^1,2,*, Huaizhou Chen¹, Changchun Guo³, Jiejing Chen¹, Hua Lin¹, Donge Tang², Wen Xue¹, Wenlong Li⁴, Weiguo Sui¹ and Yong Dai²

¹ Guangxi Key laboratory of Metabolic Diseases Research, Central Laboratory of Guilin No. 181 Hospital, 541002, Guilin, Guangxi, R.P. China
² Clinical Medical Research Center, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China
³ The Pingshan People’s Hospital of Shenzhen, Shenzhen, Guangdong 518118, P.R. China
⁴ The Technology Company of iCarbonX, Shenzhen, Guangdong 518000, P.R. China
^* These authors contributed equally to this work

Published: May 05, 2020

This article has been corrected: The 1st affiliation information was presented incorrectly. The proper affiliation 1 is as follows:

¹ Guangxi Key laboratory of Metabolic Diseases Research, Central Laboratory of Guilin No. 181 Hospital, 541002, Guilin, Guangxi, R.P. China

Original article: Oncotarget. 2018; 9:34506–34519. DOI: https://doi.org/10.18632/oncotarget.26138.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27560

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Characteristic analysis of TCR β-chain CDR3 repertoire for preand post-liver transplantation